MUNRO GORDON 4
4 · WATSON PHARMACEUTICALS INC · Filed Mar 17, 2010
Insider Transaction Report
Form 4
MUNRO GORDON
Sr. VP, Quality Assurance
Transactions
- Exercise/Conversion
Common Stock, par value $0.0033
2010-03-16$27.49/sh+18,185$499,906→ 37,046 total - Exercise/Conversion
Common Stock, par value $0.0033
2010-03-16$27.49/sh+6,815$187,344→ 43,861 total - Exercise/Conversion
Common Stock, par value $0.0033
2010-03-16$35.11/sh+4,250$149,218→ 48,111 total - Sale
Common Stock, par value $0.0033
2010-03-16$40.59/sh−4,700$190,773→ 43,411 total - Exercise/Conversion
Incentive Stock Options to Purchase Common Stock
2010-03-16−18,185→ 0 totalExercise: $27.49From: 2009-06-29Exp: 2014-06-29→ Common Stock, par value $0.0033 (18,185 underlying) - Sale
Common Stock, par value $0.0033
2010-03-16$40.61/sh−826$33,544→ 28,385 total - Sale
Common Stock, par value $0.0033
2010-03-16$40.60/sh−8,133$330,200→ 18,952 total - Exercise/Conversion
Non-Qualified Options to Purchase Common Stock
2010-03-16−6,815→ 0 totalExercise: $27.49From: 2009-06-29Exp: 2014-06-29→ Common Stock, par value $0.0033 (6,815 underlying) - Sale
Common Stock, par value $0.0033
2010-03-16$40.58/sh−9,800$397,684→ 33,611 total - Exercise/Conversion
Non-Qualified Options to Purchase Common Stock
2010-03-16−4,250→ 0 totalExercise: $35.11From: 2009-08-12Exp: 2015-08-12→ Common Stock, par value $0.0033 (4,250 underlying) - Sale
Common Stock, par value $0.0033
2010-03-16$40.63/sh−4,400$178,772→ 29,211 total - Sale
Common Stock, par value $0.0033
2010-03-16$40.62/sh−1,300$52,806→ 27,085 total - Sale
Common Stock, par value $0.0033
2010-03-16$40.64/sh−91$3,698→ 18,861 total
Footnotes (1)
- [F1]Includes shares of restricted stock issued pursuant to the Second Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.